Bryan Schneider

  • 2871 Citations
  • 26 h-Index
1976 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Vascular Endothelial Growth Factor A Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Peripheral Nervous System Diseases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1976 2015

Gene Amplification
Haplotypes
Vascular Endothelial Growth Factor A
Biomarkers
Breast Neoplasms

GENERAL CLINICAL RESEARCH CENTER

Wilkes, D., Crabb, D., Rex, D., Einhorn, L., Zipes, D., Benson, M., Moe, S., Abonour, R., Farlow, M., Miller, K., Loehrer, P., Cripe, L., Peacock, M., DiMeglio, L., Econs, M., Spinola, S., de Cordon, K., Denne, S., Kwo, P., Agarwal, R., Considine, R., Poindexter, B., Stevens, J., Kraus, M., Chalasani, N., Robertson, M., Logan, T., Croop, J., Groh, W., Robertson, M., Hannon, T., Wojcieszek, J., Considine, R., Mather, K., Chalasani, N., Flockhart, D. A., Foroud, T., Desta, Z., Benson, M., Kareken, D., Poindexter, B., Friedman, A., Gupta, S., Schneider, B., Carpenter, J., Steiner, S., Storniolo, A. M., Cripe, L., Murphy, M., Molleston, J., Hui, S., Von Ah, D., Logan, T., Sawada, S., Fineberg, S. E., Edmondson, J. W., Lumeng, L., O'Connor, K., Clark, C. M., Maxwell, D., Scott, P., Prystowsky, E., Hoffman, R., Brater, C. D., Brandt, I., Bradley, J., Vinicor, F., Williams, S., Weir, C., Heger, J., Thomasson, H., Manolagas, S., Duckworth, W., MacLaren, N., Mohler, E., Baker, J., Vargo, D., Lehman, G., Einhorm, L., Luft, F., Scheller, C., Rudy, D., Merritt, D. H., Kleit, S., Williams, D., Wheeler, M., Twigg, H., Weinberger, M., Wheat, L. J., Holden, R., Rawl, S., Smith, F. O., Shankar, R., Kirkman, S. U. E., Richardson, J., Pratt, J. H., Rodriguez, H., Hall, S., McDougle, C., Brater, D. C., Dropco, E., Krause, M., Baker, S., Wilensky, R., Hamburger, R., Jakacki, R., Oconnor, S., Rink, R., Biller, J., Prince, M., Klaunig, J., Reed, T. E., Harris, A., Myers, S., Jackson, R., Jindal, R., Haehner, B., Johnston, C. C., Black, J., McCaskill-Steve, W., Clark, C., Roos, K., Batiuk, T., Brady, M., Oconner, S., Keck, J., Brashear, A., Timmerman, R., Goldmna, M., Mohler, E. R., Guare, J., Frank, M., Siemers, E., Dropcho, E. J., Davidson, D., Pompili, V., Patrick Loehrer, M. D., Gumbiner, B., Michael Frank, M. D., Wheat, L. J., O'Connor, S., Dusick, A., Ernst, J., Sowinski, K., Batiuk, T., Rushing, D., Stout, J., Bangs, M., Sokol, G., Lemons, J., Gorski, J. C., Johnson, R., Sweeney, C., Dennis Chua, A., Dube, M., Galinsky, R. E., Steinberg, H., Pescovitz, M. D., Twigg, H., Fife, K. H., O'Connor, S. J., Tisdale, J. E., Vik, T., Govani, M., Gardner, T. W., Blekher, T., Kays, M., Johnston, C., Howenstine, M., Dusick, A., Yaqub, M., Kreher, N., Morris, E., Posey, D., Nebesio, T., Ragg, S., Kowolik, M., Ellett, M., Shankar, S., Walvoord, E., Shore, C., Deeg, M., Matei, D., Tisdale, J. E., Bruno, A., Knox, K., Stout, J., Blekher, T., Saifullah, A., Jin, Y. A. N., Griest, A., Nurnberger, J., Hathaway, D., Voelker, J., Abel, L., Faust, H., Brater, C., Garcia, J. O. E., Garvey, T., Johnston, C. C., Fergusson, J., O'Connor, S., Greist, A., Shapiro, A. M. Y., Eigen, H., Roth, B. J., Pescovitz, O., Lemons, J., Pescovitz, M., Rickard, K., Christian, J., Sokol, G., Bradley, J. D., Steinberg, H., Freidenberg, G., Wheat, J., Fife, K., Gordon, M., Pratt, H., Mannix, E., Sledge, G., Sandler, A., Baron, A., Leitch, C. & Goldman, M.

National Institutes of Health

12/1/7611/30/09

Project: Research projectGeneral Clinical Research Centers Program

salmon calcitonin
Haemophilus ducreyi
Amyloidosis
Osteoporotic Fractures
Osteoporosis

Publications 1997 2018

  • 2871 Citations
  • 26 h-Index
  • 77 Article
1 Citations

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial

Mosher, C. E., Secinti, E., Li, R., Hirsh, A. T., Bricker, J., Miller, K., Schneider, B., Storniolo, A. M., Mina, L., Newton, E. V., Champion, V. & Johns, S., Jan 12 2018, (Accepted/In press) In : Supportive Care in Cancer. p. 1-12 12 p.

Research output: Contribution to journalArticle

Acceptance and Commitment Therapy
Fatigue
Breast Neoplasms
Sleep
Telephone

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Diamond, J. R., Eckhardt, S. G., Pitts, T. M., van Bokhoven, A., Aisner, D., Gustafson, D. L., Capasso, A., Sams, S., Kabos, P., Zolman, K., Colvin, T., Elias, A. D., Storniolo, A. M., Schneider, B., Gao, D., Tentler, J. J., Borges, V. F. & Miller, K., Aug 2 2018, In : Breast Cancer Research. 20, 1, 82.

Research output: Contribution to journalArticle

Aurora Kinases
Triple Negative Breast Neoplasms
Phase II Clinical Trials
Angiogenesis Inhibitors
Microvessels

Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review

Kendzierski, D. C., Schneider, B. & Kiel, P. J., Jan 1 2018, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

Leuprolide
Appointments and Schedules
Breast Neoplasms
Aromatase Inhibitors
Estrogen Receptors

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II

Li, Y., Liu, Y., Xu, H., Jiang, G., Van der Jeught, K., Fang, Y., Zhou, Z., Zhang, L., Frieden, M., Wang, L., Luo, Z., Radovich, M., Schneider, B., Deng, Y., Liu, Y., Huang, K., He, B., Wang, J., He, X., Zhang, X. & 2 othersJi, G. & Lu, X., Dec 1 2018, In : Nature communications. 9, 1, 4394.

Research output: Contribution to journalArticle

Alpha-Amanitin
Clustered Regularly Interspaced Short Palindromic Repeats
Chromosome Deletion
deletion
Gene encoding

Identification of a genomic region between SLC29A1 and HsP90AB1 associated with risk of bevacizumab-induced hypertension: CALGB 80405 (Alliance)

Li, M., Mulkey, F., Jiang, C., O'Neil, B. H., Schneider, B., Shen, F., Friedman, P. N., Momozawa, Y., Kubo, M., Niedzwiecki, D., Hochster, H. S., Lenz, H. J., Atkins, J. N., Rugo, H. S., Halabi, S., Kelly, W. K., McLeod, H. L., Innocenti, F., Ratain, M. J., Venook, A. P. & 2 othersOwzar, K. & Kroetz, D. L., Oct 1 2018, In : Clinical Cancer Research. 24, 19, p. 4734-4744 11 p.

Research output: Contribution to journalArticle

Hypertension
Nucleic Acid Regulatory Sequences
Blood Pressure
Adenosine
Single Nucleotide Polymorphism